Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Kovačević, Mila (56781110100)"

Filter results by typing the first few letters
Now showing 1 - 1 of 1
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Characteristics and Outcomes of Patients with Acute Coronary Syndrome and COVID-19
    (2022)
    Milovančev, Aleksandra (57217948632)
    ;
    Petrović, Milovan (16234216100)
    ;
    Popadić, Višeslav (57223264452)
    ;
    Miljković, Tatjana (57204991851)
    ;
    Klašnja, Slobodan (57222576460)
    ;
    Djuran, Predrag (57223255944)
    ;
    Ilić, Aleksandra (57383582400)
    ;
    Kovačević, Mila (56781110100)
    ;
    Milosavljević, Anastazija Stojšić (6505915662)
    ;
    Brajković, Milica (56115773900)
    ;
    Crnokrak, Bogdan (57208706438)
    ;
    Memon, Lidija (13007465900)
    ;
    Milojević, Ana (57473639100)
    ;
    Todorović, Zoran (7004371236)
    ;
    Čanković, Milenko (57204401342)
    ;
    Šarkanović, Mirka Lukić (55615043800)
    ;
    Bjelić, Snežana (57546653200)
    ;
    Tadić, Snežana (57194334307)
    ;
    Redžek, Aleksandar (6508302832)
    ;
    Zdravković, Marija (24924016800)
    Acute coronary syndrome (ACS) in patients with COVID-19 is triggered by various mechanisms and can significantly affect the patient’s further treatment and prognosis. The study aimed to investigate the characteristics, major complications, and predictors of mortality in COVID-19 patients with ACS. All consecutive patients hospitalized from 5 July 2020 to 5 May 2021 for ACS with confirmed SARS-Co-2 were prospectively enrolled and tracked for mortality until 5 June 2021. Data from the electronic records for age and diagnosis, matched non-COVID-19 and COVID-19 ACS group, were extracted and compared. Overall, 83 COVID-19 ACS patients, when compared to 166 non-COVID ACS patients, had significantly more prevalent comorbidities, unfavorable clinical characteristics on admission (acute heart failure 21.7% vs. 6.6%, p < 0.01) and higher rates of major complications, 33.7% vs. 16.8%, p < 0.01, and intrahospital 30-day mortality, 6.7% vs. 26.5%, p < 0.01. The strongest predictors of mortality were aortic regurgitation, HR 9.98, 95% CI 1.88; 52.98, p < 0.01, serum creatinine levels, HR 1.03, 95% CI 1.01; 1.04, p < 0.01, and respiratory failure therapy, HR 13.05, 95% CI 3.62; 47.01, p < 0.01. Concomitant ACS and COVID-19 is linked to underlying comorbidi-ties, adverse presenting features, and poor outcomes. Urgent strategies are needed to improve the outcomes of these patients. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback